Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms, a novel strategy against infections

  • Mazzolini, Rocco|||0000-0003-3249-8387
  • Garrido, Victoria|||0000-0002-2497-7188
  • Gómez, Andromeda-Celeste|||0000-0002-0075-6903
  • Collantes, María
  • Grilló, María Jesús|||0000-0002-1819-0186
  • Piñero-Lambea, Carlos|||0000-0002-5263-3702
  • Gibert, Isidre|||0000-0003-1442-2258
  • Yero, Daniel|||0000-0002-6234-4082
  • Lluch-Senar, Maria|||0000-0001-7568-4353
Antimicrobial resistance is a major global health threat, potentially causing 8.22 million deaths annually by 2050. Polymicrobial biofilms significantly contribute to this crisis, leading to treatment failure, especially in chronic airway infections caused by Staphylococcus aureus and Pseudomonas aeruginosa, common in ventilator-associated pneumonia and cystic fibrosis. To address this, we engineered an attenuated Mycoplasma pneumoniae strain, CV8_HAD, to secrete biofilm-disrupting enzymes (PelAh, PslGh, A1-II' and Dispersin B). CV8_HAD showed strong in vitro activity against single and mixed-species biofilms of S. aureus and P. aeruginosa, and demonstrated in vivo efficacy against S. aureus biofilms in mice and mixed infections in Galleria mellonella larvae. This study establishes engineered M. pneumoniae as a promising therapeutic strategy for tackling microbial biofilms and highlights the potential of G. mellonella larvae models as an alternative to mouse models in advancing research on biofilm-targeting interventions.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Engineered Mycoplasma pneumoniae targeting dual-species bacterial biofilms: a novel strategy against infections

  • Mazzolini, Rocco
  • Garrido, Victoria
  • Gómez, Andromeda-Celeste
  • Collantes, Maria
  • Grilló, María Jesús
  • Piñero-Lambea, Carlos
  • Gibert, Isidre
  • Yero, Daniel
  • Lluch-Senar, Maria
Antimicrobial resistance is a major global health threat, potentially causing 8.22 million deaths annually by 2050. Polymicrobial biofilms significantly contribute to this crisis, leading to treatment failure, especially in chronic airway infections caused by Staphylococcus aureus and Pseudomonas aeruginosa, common in ventilator-associated pneumonia and cystic fibrosis. To address this, we engineered an attenuated Mycoplasma pneumoniae strain, CV8_HAD, to secrete biofilm-disrupting enzymes (PelAh, PslGh, A1-II' and Dispersin B). CV8_HAD showed strong in vitro activity against single and mixed-species biofilms of S. aureus and P. aeruginosa, and demonstrated in vivo efficacy against S. aureus biofilms in mice and mixed infections in Galleria mellonella larvae. This study establishes engineered M. pneumoniae as a promising therapeutic strategy for tackling microbial biofilms and highlights the potential of G. mellonella larvae models as an alternative to mouse models in advancing research on biofilm-targeting interventions., This work was supported by SNEO 20211019 (2021; Neotec; CDTI), and EUR2023-143461 (Spanish Ministry of Science and Innovation and Universities) grants. RM acknowledges to Spanish Ministry of Science and Innovation for the PTQ2020-011049 grant. ML-S also acknowledges to Talent UAB-Banc Santander programme and the Scientific Foundation of the Spanish Association Against Cancer (project reference LAB_LABAE247377LLUC) to support her role as principal investigator in the Synthetic biology group at UAB. A-CG, IG and DY also acknowledge to Spanish Ministry of Science and Innovation (PID2023-150290OB-I00) and the Catalan AGAUR (2021 SGR00092)., Peer reviewed